I'll research LIN (Linde plc) before writing the preview. Let me gather recent filings, transcripts, guidance, news, and price action.Let me read the most recent earnings release and call, plus get price action.Let me get recent price action and news to round out the preview.# Linde plc (LIN) — Q2 2026 Earnings Preview

Reports before market open, Friday, July 31, 2026 | 2026Q2 Earnings Call

1. The Setup: What Management Told Us to Expect

On the Q1 call (May 1), CFO Matt White gave explicit Q2 guidance and framed the year cautiously. Going in, the bar is clearly set:

Metric Q2 2026 Guidance Q2 2025 Actual (base) Implied Y/Y
Adjusted EPS $4.40 – $4.50 $4.09 +8% to +10%
— ex-currency — — +7% to +9% (assumes ~1% FX tailwind)
Adjusted operating margin (comp) ~30%+ 30.1% Flat-to-up
Adjusted EBITDA margin (comp) ~39%+ 39.4% Roughly stable

Full-year 2026 guidance stands at $17.60–$17.90 (+7% to +9%). The key nuance: at Q1, management raised the bottom of the range by $0.20 (on greater confidence in business resiliency) but deliberately left the top at $17.90, with White saying it was "still early to signal increased optimism" and that he'd like "a few more months" before considering a top-end raise. Q2 is that checkpoint — whether Linde lifts the high end of full-year guidance is arguably the single most important signal in this print.

2. Why This Quarter Matters

A. The top-end guidance raise is the swing factor. Linde is a "beat-and-raise-the-floor" compounder. It has now spent essentially three-plus years operating on a "no economic improvement at the midpoint" assumption, and has delivered high-single/low-double-digit EPS growth anyway via pricing, productivity, buybacks and bolt-on M&A. Investors will parse whether the macro finally justifies raising the ceiling, not just defending the floor.

B. Helium is the marginal upside lever — and it's not in guidance. This is the most-asked question on the stock (Goldman's Duffy Fischer flagged it as the #1 incoming question). Management was explicit that guidance excludes any helium improvement, so incremental price/volume is pure upside. Key facts from Q1: - Linde is ~85–90% contracted on helium; Q1 global helium sales were roughly flat (price down a couple points, volume up a couple points Y/Y). - Acute global shortages emerged from two distinct shocks: the Strait of Hormuz / Qatar supply constraint (Middle East conflict), plus a separate, more political Russian issue hitting the Chinese market. - Management's priority is long-term contracts, not spot sales — so watch for commentary on new multi-year agreements signed and whether contract pricing is beginning to "roll through."

C. Margin trajectory. White committed to full-year margin expansion "at the upper end or even above" the traditional 40–60 bps range (ex pass-through). Q1 came in at 30.0% adjusted op margin (flat Y/Y) with some regional noise — APAC dinged by a lower-margin equipment sale and seasonality (expected to recover to ~29%), EMEA dragged by weak volumes. Watch for APAC margin recovery and any EMEA self-help.

3. Regional & End-Market Scorecard (from Q1, for context)

Linde is "not running on all three cylinders":

End markets to watch: Electronics (+10% in Q1, AI-driven) with new backlog additions likely — White signaled the $7.1B sale-of-gas backlog could move to an "8-handle" by year-end. Manufacturing/aerospace strength from U.S. commercial space (Linde said it will break out aerospace as a separate segment once it exceeds ~5% of sales, i.e., ~$1.7B). Healthcare soft in U.S. home care due to a 2025 policy change (a multi-quarter headwind). Food & beverage steady.

4. Specific Items to Listen For

  1. Woodside project timing. The ATR/TNS (blue hydrogen/sequestration) phase slipped a few months into Q1 2027 on a tough U.S. Gulf Coast construction/subcontractor environment; only a partial nitrogen start-up hits 2026. Watch for any further slippage.
  2. Electronics/AI backlog wins — management had "high confidence" in announcing large new projects "shortly." A backlog above $7.1B would be a positive.
  3. Currency. Guidance assumes ~1% FX tailwind based on ~month-old forwards; White noted spot was better at Q1, implying FX upside. Broad dollar weakness in the macro backdrop supports this.
  4. Capital allocation. Q1 saw $800M of buybacks, ~$1.5B reinvested, and a 7% dividend increase (33rd consecutive year). Balance sheet is a "fortress" (adj. net debt ~$22.4B, ROC ~24%). Watch buyback pace.
  5. CEO on the call. CEO Sanjiv Lamba was not on the Q1 call (White + IR ran it); management indicated he'd return. His presence/commentary on longer-term strategy would be notable.
  6. The "algo" gap. White acknowledged Linde needs to get back to its 8–12% ex-macro EPS growth algorithm, currently dragged ~1% by helium timing and ~1% by Engineering project mix. Watch whether those drags are abating.

5. Macro & Idiosyncratic Backdrop

6. Stock Context

LIN closed around $508 on July 30, having pulled back from a ~$546 peak in early July (roughly -7%). The stock has traded in a $493–$546 band since April — consistent with a quality compounder in a "prove-it" macro. Notably, peer Air Products (APD) has meaningfully underperformed over the same stretch, reinforcing LIN's status as the premium operator in industrial gases. With shares off their highs into the print, positioning looks less demanding than a month ago — but expectations for the durable EPS-growth algorithm remain high.

Bottom Line

Linde is a low-beta compounder where the quarter itself rarely surprises much — Q1's small beat came almost entirely from FX, with the business "performing as anticipated." The three things that will actually move the stock and the narrative on July 31:

  1. Does Linde raise the top end of full-year guidance (currently pinned at $17.90)? A raise signals genuine macro confidence; a hold signals continued caution.
  2. Helium — any signs of contract pricing rolling through and new long-term volumes, which would be pure upside to guidance.
  3. Electronics/AI backlog additions pushing the project backlog toward an "8-handle," plus Americas volume momentum vs. EMEA weakness.

Base case: another in-line-to-modest-beat quarter (EPS around/above the $4.40–$4.50 range, aided by favorable FX), with the guidance-raise decision and helium commentary carrying more weight than the reported numbers.

Note: figures above are drawn from Linde's Q1 2026 release/call and prior-period disclosures; I did not find a published sell-side consensus estimate for Q2 2026 in the available sources, so company guidance ($4.40–$4.50 adjusted EPS) is the most reliable reference point.